Challenges faced after being censored on a professional platform for discussing autoimmunity in severe covid-19.
-
Being censored or removed from a platform can lead to feelings of rejection and inadequacy. • 0:23
-
LinkedIn played a crucial role in the individual’s work, research, and personal connections. • 1:04
-
A post challenging the understanding of severe covid-19 as an autoimmune disease was censored on LinkedIn. • 2:53
-
The individual published a peer-reviewed paper on the theory of autoimmunity against Ace2 in severe covid-19. • 3:58
-
The scientific principles presented by the individual are gaining recognition and support in the scientific community. • 4:15
Autoimmunity in COVID-19 research reveals potential autoimmune response to the virus, sparking concerns in the scientific community.
-
COVID-19 virus triggers autoantibodies to spike protein and ACE2, leading to autoimmune response. • 4:45
-
Challenges in conducting research on autoantibodies due to cost and sample collection issues. • 5:50
-
Study shows elevated levels of autoantibodies in convalescent and hospitalized COVID-19 patients. • 7:06
-
Revealing COVID-19 as a potential autoimmune disease poses significant implications for the future. • 8:01
-
Scientist struggles with speaking out against misinformation and censorship in the scientific community. • 8:42
Challenges of expressing concerns about immune suppression in severe conditions amidst scientific censorship.
-
Analogizes severe COVID-19 treatment with rheumatic fever immune suppression. • 9:08
-
Struggles with expressing concerns due to potential repercussions on social media platforms. • 10:08
-
Finds solace in sharing views on Substack amidst scientific censorship challenges. • 11:18
-
Expresses hope for finding answers regarding autoimmunity in COVID-19. • 11:44
-
Urges for cautious optimism and research exploration in facing potential challenges ahead. • 12:01